webinar register page

Webinar banner
Amyloidosis Support Groups Webinar on ATTRv & ATTRwt Amyloidosis
Please join us on December 5th from 12 pm - 4 pm ET for our next webinar - ATTRv & ATTRwt Amyloidosis Treatments and How They Work.

What is the difference between a stabilizer and a silencer? How do they work? Pharma Representatives explain their drugs and answer your questions. Cardiologists and neurologist on hand to answer questions too. We are asking for you to submit any questions that you may have IN ADVANCE of the webinar by emailing them to info@amyloidosissupport.org.

Physician Panelists include Dr. Chafic Karam, University of Pennsylvania, Dr. Nitasha Sarswat, University of Chicago and Dr. Brett Sperry, Saint Lukes Hospital, Dr. Jonathan Wall, University of Tennessee

Pharmaceutical Speakers:
Akcea/Ionis - Gustavo Buchele, Director, Clinical Development and
Kristina Bowyer, Vice President, Patient Centric Drug Development

Alnylam Pharmaceuticals- Akshay Vaishnaw MD, Ph.D., President of Research and Development, and
Steven Roblin, Ph.D., US Medical Director

Corino Therapeutics - Michael Roberts Ph.D., Chief Executive Officer

Eidos Therapeutics - Alan Cohen MD, Vice President, Medical Affairs and
Jocelyn Ashford, Head of Global Patient Advocacy

Intellia Therapeutics - Jeffrey Cehelsky, VP of Development Operations

Pfizer - Adam Castaño, MD MS, Senior Medical Director and
Craig Spolsky, Patient Advocacy and Professional Relations Director

Dec 5, 2020 12:00 PM in Eastern Time (US and Canada)

Webinar logo
Webinar is over, you cannot register now. If you have any questions, please contact Webinar host: Paula Schmitt.